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Introduction
Fibrodysplasia Ossificans Progressiva (FOP) is a rare
autosomal dominant connective tissue disorder charac-
terized by congenital great toes malformation and pro-
gressive heterotopic osteogenesis leading to progressive
debilitating ankylosis of the body. A recurrent missense
mutation in the activin receptor 1A/activin-like kinase 2
(ACVR1/ALK2), a bone morphogenetic protein (BMP)
receptor, was identified in almost all FOP patients
1.
Here we report two unrelated Chinese FOP adolescents
harbouring this mutation. Both were referred to the
rheumatological service with joint stiffness and abnor-
mal calcification on imaging.
Case 1
CSNM developed progressive jaw ankylosis since twelve
years of age. She started to have recurrent soft tissue
swellings involving neck, shoulders and back at sixteen.
At that time she was suffering from pulmonary tubercu-
losis. The swellings subsided spontaneously, leaving
bony hard masses.
Case 2
WCY was born with multiple congenital abnormalities
including hypospadias, atrial septal defect (ASD) and
multiple exostoses. Starting from twelve year of age, he
developed ankylosis of the left temporomandibular joint.
The first FOP flare started with a painful swelling over
his back and neck. This was followed by stiffening of
the muscles.
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Fig 1 CT images of case 1- extraosseous ossification
Fig 2 great toe abnormality of case 2
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detected in the exon 7 of the ACVR1 gene, resulting in
an Arg206His substitution.
Conclusion
Confirmation of the diagnosis of FOP is relatively more
straightforward now with the availability of molecular
genetic testing. A high index of suspicion is the key to
diagnose these patients early with unexplained recurrent
ossified swellings and congenital feet abnormalities. Unne-
cessary and often harmful biopsy procedures could be
avoided during the diagnostic workup of these patients.
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